NCT02917473 Comparison of Two Strategies for Counseling Skin Examination and Sun Protection in First-degree Relatives of Patients With Melanoma Status COMPLETED Phase NA
NCT02910557 Postmarketing Prospective Study of Melanoma Patients Treated With IMLYGIC® to Characterize Risk of Herpetic Infection Status COMPLETED Phase N/A
NCT02909348 Immunophenotyping of Melanoma Patients on Treatment With Pembrolizumab Status COMPLETED Phase N/A
NCT02908672 A Study of Atezolizumab Plus Cobimetinib and Vemurafenib Versus Placebo Plus Cobimetinib and Vemurafenib in Previously Untreated BRAFv600 Mutation-Positive Patients With Metastatic or Unresectable Locally Advanced Melanoma Status COMPLETED Phase PHASE3
NCT02907827 Whole-body DW-MRI and cfDNA Analysis for the Surveillance of Melanoma Patients at High Risk for Recurrence. Status RECRUITING Phase NA
NCT02905266 A Safety and Efficacy Study of Multiple Administration Regimens for Nivolumab Plus Ipilimumab in Subjects With Melanoma Status COMPLETED Phase PHASE3
NCT02902822 Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo Status COMPLETED Phase NA
NCT02900248 CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice Status TERMINATED Phase N/A
NCT02897765 A Personal Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer Status COMPLETED Phase PHASE1
NCT02893774 Longitudinal Study of Behavioral Changes, Economic and Sociological After CAncer Status COMPLETED Phase NA
NCT02890368 Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides Status TERMINATED Phase PHASE1
NCT02872259 BGB324 in Combination With Pembrolizumab or Dabrafenib/Trametinib in Metastatic Melanoma Status COMPLETED Phase PHASE1/PHASE2
NCT02870244 Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes Status RECRUITING Phase PHASE1
NCT02869217 Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1